Food and Drug Regulations

This version of section C.04.415 is in force from 2006-03-22 to 2006-12-13.


 A pyrogen-free anticoagulant solution shall be used in every plasmapheresis program consisting of one of the following formulae:

  • (a) Anticoagulant acid citrate dextrose solution (ACD)

    Trisodium citrate (Na3C6H5O7.2H2O)22.0 g

    Citric acid (C6H8O7.H2O)8.0 g

    Dextrose (C6H12O6H2O)24.5 g

    Water for Injection (U.S.P.) to make1 000.0 mL

  • (b) Anticoagulant citrate phosphate dextrose solution (CPD)

    Trisodium citrate (Na3C6H5O7.2H2O)26.3 g

    Citric acid (C6H8O7.H2O)3.3 g

    Dextrose (C6H12O6H2O)25.5 g

    Monobasic sodium phosphate (NaH2PO4H2O)2.2 g

    Water for Injection (U.S.P.) to make1 000.0 mL

  • (c) Anticoagulant citrate phosphate dextrose adenine solution (CPDA-I)

    Trisodium citrate (Na3C6H5O7.2H2O)26.3 g

    Citric acid (C6H8O7.H2O)3.3 g

    Dextrose (C6H12O6H2O)31.9 g

    Monobasic sodium phosphate (NaH2PO4H2O)2.2 g

    Adenine (C5H5N5)275.0 mg

    Water for Injection (U.S.P.) to make1 000.0 mL

  • (d) Anticoagulant sodium citrate solution (SC)

    Trisodium citrate (Na3C6H5O7.2H2O)40.0 g

    Water for Injection (U.S.P.) to make1 000.0 mL

  •  SOR/78-545, s. 1;
  • SOR/85-1022, s. 6.